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Abstract Vacuum-assisted closure has earned its indi-
cations in coloproctology. It has been described with vari-
able results in the treatment of large perineal defects after
abdominoperineal excision, in the treatment of stoma
dehiscence and perirectal abscesses. The most promising
indication for vacuum-assisted closure is probably the
treatment of para-anastomotic presacral abscesses follow-
ing anastomotic leakage after total mesorectal excision.
Early initiation of vacuum-assisted closure has the poten-
tial to prevent debilitating persistent presacral sinuses
precluding stoma closure and bad function of the neorec-
tum. Prompt initiation of endosponge treatment is advised
after the anastomotic leakage with the purulent cavity is
diagnosed. The endosponge is inserted transanally and
connected with a low vacuum bottle. With the gradual
reduction in the cavity, the endosponge is reduced in size
every 3–4 days when the endosponge is exchanged. It takes
3–6 weeks to close the cavity. Future studies should focus
on the stoma closure rate and function to assess whether
this intensive postoperative treatment of anastomotic
leakages is justiﬁed.
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Introduction
Anastomotic leakage is a serious and feared complication
followingcolorectalsurgeryandisassociatedwithearlyand
long-term morbidity and mortality. Particularly, (low)
anterior resections are associated with a high leakage rate
ranging up to 24% [1–3]. Nowadays, the current practice is
to perform a partial mesorectal excision for proximal rectal
tumors with a colorectal anastomosis, and a total mesorectal
excision (TME) for mid and distal tumors with a very distal
colorectal or even coloanal anastomosis. In restorative
proctocolectomy for ulcerative colitis and familial polypo-
sis, mostly the total mesorectalexcision techniqueisapplied
followed by an ileal anal pouch procedure. While removing
the total mesorectum, a large dead space is created in the
pelvis that is generally ﬁlled only partially by the neorectum
or the pouch. In case of anastomotic leakage, this cavity can
result in a presacral or paranastomotic sinus that cannot heal
properlybecauseofinsufﬁcientdrainageviatheanastomotic
defect. A defunctioning ileostomy whether performed ini-
tially or secondary because of clinical signiﬁcant anasto-
motic leakage does not prevent this presacral sinus to occur.
The cavity probably heals spontaneously when it is small.
When it is large, it might become persistent. Under these
circumstances, ileostomy closure is delayed or discarded. If
stoma closure is attempted in the presence of a persisting
sinus, the function of the neorectum or pouch is often com-
promised [4]. Even cancer has been reported in the chronic
para-anastomotic sinus [5].
Little data exist on how many of these anastomotic
leakages eventually will result in a chronic presacral sinus.
Arumainayagam et al. reported a 5% incidence in a series of
patients that had TME. Only in two out of the ﬁve persistent
sinuses, the ostomy could be closed [5]. Unpublished data
from our own institute suggested a 48% closure rate of the
persistent sinus after a median time of almost a year.
It is difﬁcult to decide how to treat a presacral para-
anastomotic sinus once it has matured. There are several
options: a wait and see policy before stoma closure hoping
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tomosis and formation of a new anastomosis; take down of
the anastomosis creating a permanent colostomy; lay-open
of the sinus into the neorectum; and installation of occlu-
sive agents, such as ﬁbrin glue. Because of the chronic
sepsis and ﬁbrotic tissue, all invasive procedures are
technically difﬁcult and complicated. The treatment
options trying to preserve the neorectum or pouch have a
low success rate with unpredictable stoma closure rates and
function. Since the chronic sinus is difﬁcult to treat, the key
to success is the prevention of this chronic presacral peri-
anastomotic ﬁstula.
Recently, Weidenhagen et al. [6] described the appli-
cation of local vacuum sponge treatment of locally con-
tained anastomotic leakage after low anterior anastomosis
in rectal cancer patients. In a series of 29 patients with
anastomotic leakage, closure of the cavity was achieved in
28 patients. The currently available vacuum sponge is the
so-called endosponge (B. Braun Medical B.V., Melsungen,
Germany). This is an open-pored polyurethane sponge,
which is installed transanally after examination and rinsing
of the abscess cavity with saline solution using a ﬂexible
endoscope of outer diameter up to 12 mm. The length and
size of the abscess cavity are estimated, and the size of the
sponge is cut accordingly. When the cavity is too large for
one sponge, multiple sponges can be placed. After the
introduction of the endoscope into the deepest point of the
cavity, a plastic tube, positioned over the scope, is
advanced into the deepest point of the cavity. After with-
drawal of the endoscope, the endosponge is inserted
through the lubricated tube by using a pushing probe while
retracting the plastic tube. Next, the sponge is connected to
a low vacuum suction bottle, creating a constant negative
pressure in the sponge. The correct positioning of the
sponge is checked with the endoscope. Fixation of the
sponge is not necessary, because low-pressure suction ﬁxes
the sponge in the abscess cavity. The endosponge is
changed every 3–4 days to prevent the tissue from growing
into the sponge causing painful sponge exchanges. Saline
solution or lidocaine solution is introduced into the sponge
just before its removal to facilitate a painless extraction.
At each exchange, the size of the sponge is reduced.
Endo-vacuum treatment can be performed in an ambulant
outpatient fashion. The vacuum that is essential for the
adequate drainage of the sponge is maintained because of
the seal induced by the anal sphincter. For this reason, the
successful treatment of the presacral cavity with the
endosponge after abdominoperineal excision is only pos-
sible if the entrance to the presacral cavity is narrow
enabling to seal this off by for instance stoma paste as
described in this issue by de Hondt et al. [7]. Endosponge
treatment will not work in large open perineal defects.
Under these circumstances, regular VAC
 treatment can be
attempted, although maintaining vacuum might be trou-
blesome. It might be useful in stoma dehiscence treatment,
as recently described by Crick et al. [8]. Moreover, in the
present issue, Durai et al. [9] describe an interesting tech-
nique as a modiﬁcation of the regular VAC
 in combina-
tion with a Redivac systems for the successful treatment of
a perirectal abscess following PPH for hemorrhoids, which
was possible due to the very short distance of the abscess
oriﬁce from the anal verge and in similar cases may rep-
resent an opportunity.
The endo-vacuum facilitates closure of the presacral
space by the application of negative pressure into the
sponge, ensuring continuous drainage and thereby infection
control. It is a misunderstanding that the cavity will be ﬁlled
with new tissue. Adequate drainage and the vacuum enable
the neorectum or pouch to expand and close the cavity.
Koperen et al. [10] indicated that the success of endosponge
treatmentdependedonthetimewhenthetreatmentisstarted
after surgery. In a multicenter study, deﬁnitive resolution of
thesinuswasachievedin9outof16patients(56%).Closure
was achieved in a median of 40 (range 28–90) days with a
median amount of 13 sponge replacements (range 8–17).
There was closure in six out of eight patients (75%) in the
group that started with the endosponge treatment within
6 weeks of surgery compared with 3 out of 8 patients (38%)
inthe groupthatstartedlater. Inthe latetreatmentgroup, the
scarredandﬁbroticneorectumisnotabletoexpandanymore
to ﬁll the presacral sinus. The excellent results of Weiden-
hagen et al. can be explained by the fact that they routinely
assessed the anastomoses shortly after surgery, in order to
initiate endosponge treatment immediately when anasto-
motic leakage was observed [6].
Conclusion
The endo-vacuum-assisted closure treatment of the pre-
sacral sinus caused by leakage after TME after resection of
both benign and malignant pathology is the most promising
application of vacuum assisted closure in coloproctology.
Future studies should focus on the stoma closure rate
and function to assess whether this intensive postoperative
treatment of anastomotic leakages is justiﬁed.
Open Access This article is distributed under the terms of the
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